Results 1 to 10 of about 385,222 (310)

Corrigendum: Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders [PDF]

open access: goldFrontiers in Molecular Neuroscience, 2018
[This corrects the article DOI: 10.3389/fnmol.2018.00387.].
Nicole M. Fisher   +5 more
doaj   +8 more sources

Can Metabotropic Glutamate Receptor 7 (mGluR 7) be a Novel Target for Analgesia? [PDF]

open access: goldJournal of Clinical and Diagnostic Research, 2014
Introduction: The present study was carried out to study the role of metabotropic glutamate receptor 7 (mGluR7) using its agonist, N,N’-bis(diphenylmethyl)-1,-ethanediamine (AMN082) for nociceptive stimuli, in animal models.
Shivaprakash G   +6 more
doaj   +7 more sources

Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders [PDF]

open access: yesFrontiers in Molecular Neuroscience, 2018
Neurodevelopmental disorders (NDDs) are characterized by a wide range of symptoms including delayed speech, intellectual disability, motor dysfunction, social deficits, breathing problems, structural abnormalities, and epilepsy.
Nicole M. Fisher   +5 more
doaj   +7 more sources

Constitutive activity of metabotropic glutamate receptor 7. [PDF]

open access: yesBMC Neurosci, 2015
BackgroundMetabotropic glutamate receptors (mGluRs) are class C G protein coupled receptors with widespread central nervous system expression. mGluR7 is a member of this family that has been implicated in numerous physiological and pathological processes,
Kammermeier PJ.
europepmc   +9 more sources

Activating metabotropic glutamate receptor‑7 attenuates visceral hypersensitivity in neonatal maternally separated rats. [PDF]

open access: hybridInt J Mol Med, 2019
Increasing evidence has indicated that metabotropic glutamate receptor-7 (mGluR7) is an important target for reducing anxiety and stress-associated behaviours.
Shao L   +5 more
europepmc   +7 more sources

A large consanguineous family with a homozygous Metabotropic Glutamate Receptor 7 (mGlu7) variant and developmental epileptic encephalopathy: Effect on protein structure and ligand affinity [PDF]

open access: yesOrphanet Journal of Rare Diseases, 2021
Background Developmental and epileptic encephalopathies (DEE) are chronic neurological conditions where epileptic activity contributes to the progressive disruption of brain function, frequently leading to impaired motor, cognitive and sensory ...
Marwa Ben Jdila   +6 more
doaj   +3 more sources

Metabotropic Glutamate Receptor 7: From Synaptic Function to Therapeutic Implications. [PDF]

open access: yesCurr Neuropharmacol, 2016
Metabotropic glutamate receptor 7 (mGluR7) is localized presynaptically at the active zone of neurotransmitter release. Unlike mGluR4 and mGluR8, which share mGluR7’s presynaptic location, mGluR7 shows low affinity for glutamate and is activated only by ...
Palazzo E   +4 more
europepmc   +7 more sources

G-alpha interacting protein interacting protein, C terminus 1 regulates epileptogenesis by increasing the expression of metabotropic glutamate receptor 7. [PDF]

open access: greenCNS Neurosci Ther, 2022
It has been reported that the G‐alpha interacting protein (GAIP) interacting protein, C terminus 1 (GIPC1/GIPC) engages in vesicular trafficking, receptor transport and expression, and endocytosis. However, its role in epilepsy is unclear.
Liu Y   +7 more
europepmc   +4 more sources

Metabotropic Glutamate Receptor 7 (mGluR7) as a Target for the Treatment of Psychostimulant Dependence. [PDF]

open access: yesCNS Neurol Disord Drug Targets, 2015
Although few medications have been approved by the U.S. Food and Drug Administration (FDA) to assist people to quit tobacco smoking, there are no FDA-approved medications to treat dependence on other psychostimulant drugs, such as cocaine. The motivation
Li X, Markou A.
europepmc   +6 more sources

Activation of Metabotropic Glutamate Receptor 7 Is Required for Induction of Long-Term Potentiation at SC-CA1 Synapses in the Hippocampus. [PDF]

open access: hybridJ Neurosci, 2015
Of the eight metabotropic glutamate (mGlu) receptor subtypes, only mGlu7 is expressed presynaptically at the Schaffer collateral (SC)-CA1 synapse in the hippocampus in adult animals. Coupled with the inhibitory effects of Group III mGlu receptor agonists
Klar R   +9 more
europepmc   +4 more sources

Home - About - Disclaimer - Privacy